News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,826 Results
Type
Article (39731)
Company Profile (247)
Press Release (659848)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204184)
Career Advice (2008)
Deals (35420)
Drug Delivery (95)
Drug Development (81052)
Employer Resources (172)
FDA (16189)
Job Trends (14864)
News (345222)
Policy (32544)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49444)
ALS (95)
Alzheimer's disease (1383)
Antibody-drug conjugate (ADC) (132)
Approvals (16186)
Artificial intelligence (261)
Autoimmune disease (22)
Automation (17)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (175)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (290)
Cancer (2311)
Cardiovascular disease (179)
Career advice (1677)
Career pathing (30)
CAR-T (154)
Cell therapy (433)
Cervical cancer (20)
Clinical research (66075)
Collaboration (854)
Company closure (2)
Compensation (565)
Complete response letters (19)
COVID-19 (2590)
CRISPR (41)
C-suite (249)
Cystic fibrosis (101)
Data (2315)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6379)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (86995)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112624)
Executive appointments (737)
FDA (17559)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (765)
Gene editing (109)
Generative AI (19)
Gene therapy (311)
GLP-1 (717)
Government (4427)
Grass and pollen (4)
Guidances (156)
Healthcare (18818)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2735)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (98)
Interviews (312)
IPO (16522)
IRA (40)
Job creations (3633)
Job search strategy (1422)
Kidney cancer (10)
Labor market (43)
Layoffs (475)
Leadership (17)
Legal (7910)
Liver cancer (76)
Lung cancer (324)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (323)
MASH (76)
Medical device (13382)
Medtech (13387)
Mergers & acquisitions (19466)
Metabolic disorders (706)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1934)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (40)
Obesity (371)
Opinion (205)
Ovarian cancer (80)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (150)
Partnered (21)
Patents (242)
Patient recruitment (115)
Peanut (46)
People (57336)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20583)
Phase II (29105)
Phase III (21671)
Pipeline (1356)
Policy (147)
Postmarket research (2563)
Preclinical (8756)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (383)
Real estate (5907)
Recruiting (65)
Regulatory (22323)
Reports (47)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (131)
Series B (87)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3579)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (30)
Vaccines (697)
Venture capitalists (42)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Today (61)
Last 7 days (961)
Last 30 days (2989)
Last 365 days (32394)
2025 (11723)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37877)
Australia (6190)
California (6379)
Canada (2060)
China (535)
Colorado (271)
Connecticut (278)
Delaware (157)
Europe (81387)
Florida (950)
Georgia (213)
Idaho (57)
Illinois (545)
India (25)
Indiana (320)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (918)
Massachusetts (4735)
Michigan (224)
Minnesota (402)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1785)
New Mexico (28)
New York (1797)
North Carolina (985)
North Dakota (8)
Northern California (2811)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1421)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (25)
South Dakota (1)
Southern California (2401)
Tennessee (105)
Texas (945)
United States (23895)
Utah (188)
Virginia (151)
Washington D.C. (64)
Washington State (562)
West Virginia (3)
Wisconsin (56)
699,826 Results for "curebase inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Curebase Announces Omnisite™ Offering to Recruit and Enroll Patients Anywhere
Curebase, a company committed to democratizing access to clinical studies and a leader in decentralized clinical trial execution, is now offering Omnisite™, a flexible site model that leverages a number of the company’s existing capabilities to reach patients where they are at home and in real-world medical settings.
June 13, 2023
·
2 min read
Business
Curebase and BEKHealth Join Forces to Expand Access to Decentralized Clinical Trials
Curebase to Leverage BEKHealth’s Integrated Clinical Research Platform to More Easily Find and recruit Decentralized Trial Participants, Expand into Oncology and New Therapeutic Areas.
November 15, 2022
·
3 min read
Business
Curebase Partners with Redenlab to Expand Data Capture Capabilities in Pharma Trials
Curebase, a company dedicated to democratizing clinical trials through a decentralized model is announcing its partnership with Redenlab, a global leader for speech testing in industry-run clinical trials.
December 1, 2022
·
2 min read
Biotech Bay
Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics trials that accelerates enrollment and allows sponsors to launch their studies faster.
January 24, 2023
·
3 min read
Business
Curebase Names Medical Research Veteran Sean Lynch as VP of Clinical Operations
Curebase, a company committed to democratizing access to clinical studies, has named veteran clinical research executive Sean Lynch as vice president of clinical operations.
August 23, 2022
·
2 min read
Press Releases
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
May 8, 2025
·
4 min read
Press Releases
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
May 7, 2025
·
3 min read
Business
Curebase Adds Two Clinical Trial Veterans to Kick-off New Advisory Board
Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.
February 14, 2022
·
3 min read
Press Releases
Exagen Inc. Prices Public Offering of Common Stock
May 8, 2025
·
3 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025
May 7, 2025
·
5 min read
1 of 69,983
Next
